Key result
BK channel activator BMS-191011 reduces hypertension and cardiac fibrosis in mice via NFκB-NLRP3 inhibition.
Why the study?
Does BK channel activation with BMS-191011 reduce Ang II-induced hypertension and cardiac fibrosis in a mouse model?
Does BK channel activation with BMS-191011 reduce Ang II-induced hypertension and cardiac fibrosis in a mouse model?
BK channel activation with BMS-191011 ameliorates Ang II-induced hypertension and cardiac fibrosis via modulation of the NFκB-NLRP3 pathway in a preclinical model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for BK channel openers in hypertensive heart disease; clinical translation remains untested.
Background Hypertension-induced cardiac fibrosis leads to heart failure. Large-conductance calcium-activated potassium (BK) channels regulate vascular tone, and their activation may mitigate fibrosis. This study explores the impact of BK channel activation on angiotensin II (Ang II)-induced hypertension and cardiac fibrosis and its effects on nuclear factor-kappa B (NFκB) signaling. Methods Male C57BL/6 J mice were infused with Ang II for 4 weeks to induce hypertension and cardiac fibrosis. The BK channel activator BMS-191011 was administered via intraperitoneal injection. Cardiac tissue was analyzed using histology, Western blotting and qPCR. Single channel recordings were used to analyze the activation of BKα channels. A dihydroethidium (DHE) Assay was used to detect superoxide (ROS) production. Superoxide Dismutase (SOD) was measured using a colorimetric activity kit. In vitro , macrophages (RAW 264.7) were stimulated with Ang II, to detect NFκB activation and macrophage polarization. Results The expression of BKα mRNA and protein abundance was decreased while markers of cardiac fibrosis (fibronectin, vimentin, αSMA and TGF-β) and ROS production were increased in the hearts of Ang II-induced hypertensive mice. In addition, macrophage infiltration was significantly increased along with inflammatory cytokines IFNγ, IL-6, IL-4, IL-10 and TNFα. The BK channel opener, BMS-191011, significantly reduced hypertension, cardiac fibrosis, and ROS production, but restored SOD in the hearts of Ang II-treated mice. In cultured macrophages, we found that Ang II increased inflammatory cytokines through NFκB-NLRP3-caspase-1 signaling. After Ang II treatment, BK channel activation inhibited NFκB, NLRP3 and caspase-1 expression. BK channel activation also suppressed NFκB-NLRP3 signaling, leading to reduced ROS accumulation and restored SOD activity. Conclusion BK channel activation reduces Ang II-induced hypertension and cardiac fibrosis by modulating oxidative stress, inflammation and macrophage polarization through the NFκB-NLRP3 pathway. These findings implicate BK channel activators as a potential novel therapeutic strategy for hypertensive cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question. BK channel activation with BMS-191011 significantly reduced hypertension, cardiac fibrosis, and oxidative stress in Angiotensin II-treated mice by inhibiting the NFκB-NLRP3 pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: